APAC Molecular Diagnostics Market, Forecast to 2021

APAC Molecular Diagnostics Market, Forecast to 2021

The molecular diagnostics (MDx) market in APAC is witnessing rapid growth due to two main factors: the high adoption of MDx tests for infectious diseases applications in emerging countries, and the advent of innovative diagnostic solutions in cancer and NGS based solutions that are gaining pace in Asia. Multinational companies have not only identified Asia as a market for future growth but have significantly invested in R&D efforts to cater to the Asian population. Genomic studies on Asian population in disease areas like oncology for targeted therapies are constantly on a rise, with active efforts from pharmaceutical and IVD companies. The rise of the private healthcare sector in Asia, with the improvement of socio-economic conditions and the growth of a wealthy middle class, has increased the quest for affordable and quality healthcare across the region.

The total MDx industry has been segmented into 4 major areas: infectious diseases, oncology, genetic disorders, and pharmacogenomics. The APAC MDx market was worth $1.72 Billion in 2016 and is expected to reach $2.86 Billion by 2021, at a CAGR of 10.7%. Infectious disease represents the highest market share of 72.0%, followed by oncology (14.3%), genetic disorders (10.0%) and pharmacogenomics (3.7%).

Cancer incidence has gone up significantly in Asia. Under genetic disorders, non-invasive prenatal testing (NIPT) has great potential with excellent opportunities for future growth. On the technology front, conventional PCR technology is being upgraded with multiplexing capabilities and introduction of automated solutions to cater to high volumes. NGS solutions are gradually making inroads into Asia, especially in developed markets like Singapore, Japan, and South Korea.

This study highlights the growing prominence of MDx industry in Asia, regional trends, growth opportunities, competitive dynamics, and a regional chapter for each of the 11 countries covered in this study.

Area of opportunity in MDx market in the APAC:
• The MDx market in the APAC is evolving with increasing access to established NATs in emerging countries as a result of revamped healthcare practices across the region.
• Oncology care has taken a new dimension in APAC, with the simultaneous rise in prevalence and demand for innovative drugs beyond conventional chemotherapy drugs.
• CDx based oncology drugs are on the rise in the region, with studies targeted for Asian population to demonstrate value. For example, Ono Pharmaceutical’s research on identifying a CDx for Opdivo, introduced in 2014 to stratify patient population.
• Novel genomic tools and technologies are foraying into the APAC to harness the future growth opportunities in the dynamic healthcare ecosystem.

Key questions this study will answer:
• What is the impact of MDx on the IVD industry, given the present healthcare scenario in the APAC?
• Who are the key industry participants in this highly fragment market?
• What are multiple factors impending the growth of MDx in the APAC?
• What are the service delivery models adapted by stakeholders across this region?
• What are the market access strategies for MDx companies aspiring to enter the APAC?
• What is the future of the molecular diagnostics market in the APAC?


  • Forecast Methodology
  • Executive Summary
    • Key Findings
    • Scope and Segmentation
    • Market Overview—Key Questions
    • Market Engineering Measurements
    • Market Overview—Definitions
    • 8 Big Market Themes for APAC MDx
    • Trends/Factors Impacting the APAC MDx Market
    • Key Companies to Watch
    • Key Predictions
    • MDx—Transition from Present to Future
  • Market Overview
    • Market Segmentation
    • Market Overview—Segmentation by Application
    • Role of Molecular Biomarkers in Pharma R&D
    • Market Overview—Life Cycle Analysis
  • Competitive Playbook
    • Key Mergers, Acquisitions, &Partnerships
  • Drivers and Restraints—Total Molecular Diagnostics Market
    • Market Drivers
    • Drivers Explained
    • Market Restraints
    • Restraints Explained
  • Forecast and Trends—Total Molecular Diagnostics Market
    • Market Engineering Measurements
      • Table Total Molecular Diagnostics Market: Market Engineering Measurements, APAC, 2016
    • Total Molecular Diagnostics Market—Revenue Forecast
      • Table Total Molecular Diagnostics Market: Revenue Forecast, APAC, 2014–2021
    • Revenue Forecast Discussion
    • Percent Revenue Forecast by Country
    • Revenue Forecast by Country
      • Table Total Molecular Diagnostics Market: Revenue Forecast by Country, APAC, 2014–2021
    • Snapshot of Market Participants
    • Market Snapshot
  • Competitive Environment
    • Market Share by Companies
    • Competitive Positioning—Seegene
    • Competitive Positioning—Roche
    • Competitive Positioning—ThermoFisher
    • Competitive Positioning—Qiagen
    • Competitive Positioning—Sysmex
  • Growth Opportunities
    • Growth Opportunities—Synergy of 3Ps in APAC
    • Growth Opportunities—Clinical Trials Market in APAC
    • Growth Opportunities
    • Trends for the Adoption of MDx Services in APAC
    • Future Trends—Direct to Consumer Testing
    • Future Trends—Niche Clusters to Watch Out for
    • Future Trends—Point-of-Care Testing (POCT) in MDx
    • Future Trends—Lifestyle Genomics in APAC
    • Genome Asia-100K
  • Technology Segments—An Overview
    • Polymerase Chain Reaction (PCR)
    • PCR—Technology Snapshot
    • In-situ Hybridization (ISH)
    • Next-Generation Sequencing (NGS)
    • Cost Implications of NGS
    • Future of NGS Platform
    • Drivers for Technology Platforms
    • MDx Test by Application Scenarios
  • Clinical Application Segment Analysis—Infectious Disease Segment
    • Infectious Disease Segment—Revenue Forecast
      • Table Infectious Disease Segment: Revenue Forecast, APAC, 2014–2021
    • Revenue Forecast Discussion
  • Oncology Segment
    • Oncology Segment—Revenue Forecast
      • Table Oncology Segment: Revenue Forecast, APAC, 2014–2021
    • Revenue Forecast Discussion
  • Genetic Disorders Segment
    • Genetic Disorders Segment—Revenue Forecast
      • Table Genetic Disorders Segment: Revenue Forecast, APAC, 2014–2021
    • Revenue Forecast Discussion
  • Pharmacogenomics Segment
    • Pharmacogenomics Segment—Revenue Forecast
      • Table Pharmacogenomics Segment: Revenue Forecast, APAC, 2014–2021
    • Revenue Forecast Discussion
  • Regional Forecast Trends and Opportunities—China Molecular Diagnostics Market
    • Market Engineering Measurements
      • Table Molecular Diagnostics Industry: Market Engineering Measurements, China, 2016
    • China Market—Revenue Forecast
      • Table Molecular Diagnostics Market: Revenue Forecast, China, 2014–2021
    • Revenue Forecast Discussion
    • China—Market Drivers
    • China—Market Restraints
    • Competitive Structure
  • South Korea Molecular Diagnostics Market
    • Market Engineering Measurements
      • Table Molecular Diagnostics Market: Market Engineering Measurements, South Korea, 2016
    • South Korea Market—Revenue Forecast
      • Table Molecular Diagnostics Market: Revenue Forecast, South Korea, 2014–2021
    • Revenue Forecast Discussion
    • South Korea—Market Drivers
    • South Korea—Market Restraints
    • Competitive Structure
  • India Molecular Diagnostics Market
    • Market Engineering Measurements
      • Table Molecular Diagnostics Market: Market Engineering Measurements, India, 2016
    • India Market—Revenue Forecast
      • Table Molecular Diagnostics Market: Revenue Forecast, India, 2014–2021
    • Revenue Forecast Discussion
    • India—Market Drivers
    • India—Market Restraints
    • Competitive Structure
  • Japan Molecular Diagnostics Market
    • Market Engineering Measurements
      • Table Molecular Diagnostics Market: Market Engineering Measurements, Japan, 2016
    • Japan Market—Revenue Forecast
      • Table Molecular Diagnostics Market: Revenue Forecast, Japan, 2014–2021
    • Revenue Forecast Discussion
    • Japan—Market Drivers
    • Japan—Market Restraints
    • Competitive Structure
  • Australia Molecular Diagnostics Market
    • Market Engineering Measurements
      • Table Molecular Diagnostics Market: Market Engineering Measurements, Australia, 2016
    • Australia Market—Revenue Forecast
      • Table Molecular Diagnostics Market: Revenue Forecast, Australia, 2014–2021
    • Revenue Forecast Discussion
    • Australia—Market Drivers
    • Australia—Market Restraints
    • Competitive Structure
  • Taiwan Molecular Diagnostics Market
    • Market Engineering Measurements
      • Table Molecular Diagnostics Market: Market Engineering Measurements, Taiwan, 2016
    • Taiwan Market—Revenue Forecast
      • Table Molecular Diagnostics Market: Revenue Forecast, Taiwan, 2014–2021
    • Revenue Forecast Discussion
    • Taiwan—Market Drivers
    • Taiwan—Market Restraints
    • Competitive Structure
  • Indonesia Molecular Diagnostics Market
    • Market Engineering Measurements
      • Table Molecular Diagnostics Market: Market Engineering Measurements, Indonesia, 2016
    • Indonesia Market—Revenue Forecast
      • Table Molecular Diagnostics Market: Revenue Forecast, Indonesia, 2014–2021
    • Revenue Forecast Discussion
    • Indonesia—Market Drivers
    • Indonesia—Market Restraints
    • Competitive Structure
  • Malaysia Molecular Diagnostics Market
    • Market Engineering Measurements
      • Table Molecular Diagnostics Market: Market Engineering Measurements, Malaysia, 2016
    • Malaysia Market—Revenue Forecast
      • Table Molecular Diagnostics Market: Revenue Forecast, Malaysia, 2014–2021
    • Revenue Forecast Discussion
    • Malaysia—Market Drivers
    • Malaysia—Market Restraints
    • Competitive Structure
    • Key Trends—Challenges and Opportunities
  • Thailand Molecular Diagnostics Market
    • Market Engineering Measurements
      • Table Molecular Diagnostics Market: Market Engineering Measurements, Thailand, 2016
    • Thailand Market—Revenue Forecast
      • Table Molecular Diagnostics Market: Revenue Forecast, Thailand, 2014–2021
    • Revenue Forecast Discussion
    • Thailand—Market Drivers
    • Thailand—Market Restraints
    • Competitive Structure
  • Singapore Molecular Diagnostics Market
    • Market Engineering Measurements
      • Table Molecular Diagnostics Market: Market Engineering Measurements, Singapore, 2016
    • Singapore Market—Revenue Forecast
      • Table Molecular Diagnostics Market: Revenue Forecast, Singapore, 2014–2021
    • Revenue Forecast Discussion
    • Singapore—Market Drivers
    • Singapore—Market Restraints
    • Competitive Structure
  • Philippines Molecular Diagnostics Market
    • Market Engineering Measurements
      • Table Molecular Diagnostics Market: Market Engineering Measurements, Philippines, 2016
    • Philippines Market—Revenue Forecast
      • Table Molecular Diagnostics Market: Revenue Forecast, Philippines, 2014–2021
    • Revenue Forecast Discussion
    • Philippines—Market Drivers
    • Philippines—Market Restraints
    • Competitive Structure
  • Vietnam Molecular Diagnostics Market
    • Market Engineering Measurements
      • Table Molecular Diagnostics Market: Market Engineering Measurements, Vietnam, 2016
    • Vietnam Market—Revenue Forecast
      • Table Molecular Diagnostics Market: Revenue Forecast, Vietnam, 2014–2021
    • Revenue Forecast Discussion
    • Vietnam—Market Drivers
    • Vietnam—Market Restraints
    • Competitive Structure
  • Conclusion
    • The Last Word—Three Big Predictions
    • Key Conclusions
  • Appendix
    • Market Engineering Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook